What We Do
Transformative Therapies for Autoimmune Disease
Translating the biology of regulatory T cells into transformational medicines for patients.
The Abata Approach
A New Era: Treg Cell Therapy
Our targeted, autologous Treg cell therapies for progressive multiple sclerosis and other serious autoimmune diseases stop immune-mediated destruction, restore homeostasis – a state of harmony – and promote repair in affected tissues.

Press Release
Abata Therapeutics Announces First Development Candidate, ABA-101, a Novel Treg Cell Therapy for the Treatment of Progressive Multiple Sclerosis
ABA-101 aims to benefit a subset of progressive MS patients with no treatment options. ABA-101 is currently in IND-enabling studies and on track to enter the clinic in 2024.